1887

n African Journal of Psychiatry - Duloxetine as an SNRI treatment for generalized anxiety disorder (GAD) : results from a placebo and active-controlled trial : product news

Volume 13, Issue 4
  • ISSN : 1994-8220
USD

 

Abstract

Characterized by persistent, difficult-to-control, chronic worry, GAD is a prominent anxiety disorder owing to its pervasiveness, chronicity, and functional impairment. The underlying neurobiology of GAD suggests involvement of several neurotransmitter systems, including serotonin, norepinephrine, and g-aminobutyric acid (GABA) transmission. In this context, the development of dual-reuptake inhibitors of serotonin and norepinephrine (SNRIs) has been particularly useful and promising for the treatment of GAD.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/medjda2/13/4/EJC72820
2010-09-01
2016-12-11

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error